VALEANT PHARMACEUTICALS INTL

VRX stock holders 13F

8 superinvestors reported owning VRX (Common Stock) according to the gurus' 2015 Q2 reports.

Top 5 gurus who own (VRX) VALEANT PHARMACEUTICALS INTL

The top 5 super investors (holders) owning VRX (by the percentage (%) of portfolio) are Glenn Greenberg - Brave Warrior Advisors (36.57%), Bill Ackman - Pershing Square Capital Management (29.95%), Jeffrey Ubben - ValueAct Holdings (17.54%), Nathaniel Simons - Meritage Group (6.99%) and Francois Rochon - Giverny Capital (5.35%) as of their 2015 Q2 reports.

To check the latest activities of the top VRX shareholders between value investors, please click on the "Activity" tab.

To see the historical data of VRX's holders please click on the "2015 Q2" dropdown menu and select the date.

# of holders: 8

Period: 2015 Q2

Type: Common Stock

History

% change to
Portfolio

Bill Ackman

Pershing Square Capital Management

29.95%

19,473,933

$222.15

$4,326,134,000

Francois Rochon

Giverny Capital

5.35%

120,382

$222.15

$26,743,000

-21.87% (-33,698)

-1.50%

Glenn Greenberg

Brave Warrior Advisors

36.57%

5,701,010

$222.15

$1,266,479,000

-2.99% (-176,006)

-1.13%

Jeffrey Ubben

ValueAct Holdings

17.54%

10,645,925

$222.15

$2,364,992,250

-22.65% (-3,116,627)

-5.14%

Nathaniel Simons

Meritage Group

6.99%

1,342,567

$222.15

$298,251,000

-0.10% (-1,403)

-0.01%

Ole Andreas Halvorsen

Viking Global Investors

3.87%

4,616,738

$222.15

$1,025,608,000

+13.76% (+558,395)

+0.47%

Ravenel Boykin Curry IV

Eagle Capital Management

2.99%

3,164,957

$222.15

$703,095,275

-9.52% (-332,954)

-0.31%

Stephen Mandel

Lone Pine Capital

5.24%

5,310,143

$222.15

$1,179,648,000

-4.66% (-259,317)

-0.26%

AVG reported hold price*: $222.15

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.